Clinical trial · Observational
Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT)
Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a non randomized, monocentric, descriptive, transversal and prospective study. The purpose of this study is to assess the compliance with patient expressed choice regarding subsequent care and death -if occured- site (at hospital or at home) after hospitalisation for terminally ill patients with an onco-hematologic solid tumor in palliative care and to identify reasons for potential non-compliance.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Malignancy | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
| Tumor, Solid | Solid Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Patients with an onco-hematologic solid tumor in palliative care
Primary outcomes (1)
- measure
- Number of patients for which their choice of care and death -if occured- site (at hospital or at home) is respected.
- timeFrame
- 2 months after inclusion
- description
- Patients will fill out a questionnaire at inclusion and 2 months after inclusion if they are still alive. Death site will be collected from primary care physician if patient died. The patient expressed choice regarding subsequent care and death site collected in the first questionnaire at inclusion will be compared to the situation at 2 months.
Secondary outcomes (3)
- measure
- Number of new hospitalisations occuring after inclusion, if any.
- timeFrame
- 2 months after inclusion
- measure
- Duration of new hospitalisations occuring after inclusion, if any.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients must be ≥ 18 years old * Patients with onco-hematologic solid tumor (locally advanced or metastatic) against which specific and systemic treatments are outdated or have been stopped (symptomatic palliation with radiotherapy is allowed) * Patients admitted in full hospitalisation * Patients able to speak, read and understand French * Patients able to answer the phone * Signed informed consent from the patient * Patients must have a social security coverage Exclusion Criteria: * Patients \< 18 years old or incapable person ≥ 18 years old * Patients admitted for any surgical intervention * Patients unable to read French * Patients whose physical or psychological condition do not allow them to answer orally or in writing * Patients deprived of liberty * Patients placed under judicial protection * Women that are pregnant or breast-feeding
References
Publications (0)
Data not yet available